183 related articles for article (PubMed ID: 21461594)
1. Identifying high-risk individuals for cardiovascular disease: similarities between venous and arterial thrombosis in perspective. A 2011 update.
Di Minno MN; Tufano A; Ageno W; Prandoni P; Di Minno G
Intern Emerg Med; 2012 Feb; 7(1):9-13. PubMed ID: 21461594
[TBL] [Abstract][Full Text] [Related]
2. Arterial and venous thrombosis by high platelet count and high hematocrit: 108 521 individuals from the Copenhagen General Population Study.
Warny M; Helby J; Birgens HS; Bojesen SE; Nordestgaard BG
J Thromb Haemost; 2019 Nov; 17(11):1898-1911. PubMed ID: 31309714
[TBL] [Abstract][Full Text] [Related]
3. Incidence of major adverse cardiovascular events among patients with provoked and unprovoked venous thromboembolism: Findings from the Registro Informatizado de Enfermedad Tromboembólica Registry.
Golemi I; Cote L; Iftikhar O; Brenner B; Tafur A; Bikdeli B; Fernández-Capitán C; Pedrajas JM; Otero R; Quintavalla R; Monreal M;
J Vasc Surg Venous Lymphat Disord; 2020 May; 8(3):353-359.e1. PubMed ID: 31784355
[TBL] [Abstract][Full Text] [Related]
4. Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition).
Bates SM; Greer IA; Pabinger I; Sofaer S; Hirsh J
Chest; 2008 Jun; 133(6 Suppl):844S-886S. PubMed ID: 18574280
[TBL] [Abstract][Full Text] [Related]
5. Risk of future arterial cardiovascular events in patients with idiopathic venous thromboembolism.
Green D
Hematology Am Soc Hematol Educ Program; 2009; ():259-66. PubMed ID: 20008208
[TBL] [Abstract][Full Text] [Related]
6. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis.
Cavallari I; Morrow DA; Creager MA; Olin J; Bhatt DL; Steg PG; Storey RF; Cohen M; Scirica BS; Piazza G; Goodrich EL; Braunwald E; Sabatine MS; Bonaca MP
Circulation; 2018 Feb; 137(7):684-692. PubMed ID: 29084737
[TBL] [Abstract][Full Text] [Related]
7. Systemic treatments for the prevention of venous thrombo-embolic events in paediatric cancer patients with tunnelled central venous catheters.
Schoot RA; Kremer LC; van de Wetering MD; van Ommen CH
Cochrane Database Syst Rev; 2013 Sep; (9):CD009160. PubMed ID: 24026801
[TBL] [Abstract][Full Text] [Related]
8. Impact of incident venous thromboembolism on risk of arterial thrombotic diseases.
Lind C; Flinterman LE; Enga KF; Severinsen MT; Kristensen SR; Braekkan SK; Mathiesen EB; Njølstad I; Cannegieter SC; Overvad K; Hansen JB
Circulation; 2014 Feb; 129(8):855-63. PubMed ID: 24270266
[TBL] [Abstract][Full Text] [Related]
9. Venous thromboembolism in cancer patients.
Deng A; Galanis T; Graham MG
Hosp Pract (1995); 2014 Dec; 42(5):24-33. PubMed ID: 25485915
[TBL] [Abstract][Full Text] [Related]
10. Venous thromboembolic prophylaxis after simultaneous bilateral total knee arthroplasty: aspirin
Goel R; Fleischman AN; Tan T; Sterbis E; Huang R; Higuera C; Parvizi J; Rothman RH
Bone Joint J; 2018 Jan; 100-B(1 Supple A):68-75. PubMed ID: 29292343
[TBL] [Abstract][Full Text] [Related]
11. Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaboration.
Simes J; Becattini C; Agnelli G; Eikelboom JW; Kirby AC; Mister R; Prandoni P; Brighton TA;
Circulation; 2014 Sep; 130(13):1062-71. PubMed ID: 25156992
[TBL] [Abstract][Full Text] [Related]
12. Arterial cardiovascular events, statins, low-dose aspirin and subsequent risk of venous thromboembolism: a population-based case-control study.
Sørensen HT; Horvath-Puho E; Søgaard KK; Christensen S; Johnsen SP; Thomsen RW; Prandoni P; Baron JA
J Thromb Haemost; 2009 Apr; 7(4):521-8. PubMed ID: 19192118
[TBL] [Abstract][Full Text] [Related]
13. Increased risk and severity of unprovoked venous thromboembolism with clustering cardiovascular risk factors for atherosclerosis: Results of the REMOTEV registry.
Gaertner S; Cordeanu EM; Mirea C; Frantz AS; Auger C; Bilbault P; Ohlmann P; Schini-Kerth V; Stephan D
Int J Cardiol; 2018 Feb; 252():169-174. PubMed ID: 29169908
[TBL] [Abstract][Full Text] [Related]
14. Carotid atherosclerosis predicts future myocardial infarction but not venous thromboembolism: the Tromso study.
Hald EM; Lijfering WM; Mathiesen EB; Johnsen SH; Løchen ML; Njølstad I; Wilsgaard T; Rosendaal FR; Brækkan SK; Hansen JB
Arterioscler Thromb Vasc Biol; 2014 Jan; 34(1):226-30. PubMed ID: 24177328
[TBL] [Abstract][Full Text] [Related]
15. [What do have arterial and venous disease in common?].
Piťha J; Auzký O; Roztočil K
Vnitr Lek; 2014 Nov; 60(11):985-9. PubMed ID: 25600046
[TBL] [Abstract][Full Text] [Related]
16. Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism.
Robertson L; Strachan J
Cochrane Database Syst Rev; 2017 Feb; 2(2):CD006771. PubMed ID: 28195640
[TBL] [Abstract][Full Text] [Related]
17. Diagnosis and initial treatment of venous thromboembolism in patients with cancer.
Streiff MB
J Clin Oncol; 2009 Oct; 27(29):4889-94. PubMed ID: 19738109
[TBL] [Abstract][Full Text] [Related]
18. Perioperative Venous Thromboembolism: A Review.
Gordon RJ; Lombard FW
Anesth Analg; 2017 Aug; 125(2):403-412. PubMed ID: 28640782
[TBL] [Abstract][Full Text] [Related]
19. Aspirin and other antiplatelet drugs in the prevention of venous thromboembolism.
Watson HG; Chee YL
Blood Rev; 2008 Mar; 22(2):107-16. PubMed ID: 18226435
[TBL] [Abstract][Full Text] [Related]
20. Philadelphia-negative myeloproliferative neoplasms among Kuwaiti Nationals.
Alshemmari S; Almazyad M; Alwehaib A; Ameen R
Cancer Med; 2021 Jan; 10(1):365-371. PubMed ID: 33280271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
